These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 21173438)
1. Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats. Gyrd-Hansen D; Halvorsen P; Nexøe J; Nielsen J; Støvring H; Kristiansen I Med Decis Making; 2011; 31(1):E1-10. PubMed ID: 21173438 [TBL] [Abstract][Full Text] [Related]
2. Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information? Stovring H; Gyrd-Hansen D; Kristiansen IS; Nexoe J; Nielsen JB BMC Med Inform Decis Mak; 2008 Jun; 8():25. PubMed ID: 18565218 [TBL] [Abstract][Full Text] [Related]
3. How do individuals apply risk information when choosing among health care interventions? Gyrd-Hansen D; Kristiansen IS; Nexøe J; Nielsen JB Risk Anal; 2003 Aug; 23(4):697-704. PubMed ID: 12926563 [TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats. Sheridan SL; Pignone MP; Lewis CL J Gen Intern Med; 2003 Nov; 18(11):884-92. PubMed ID: 14687273 [TBL] [Abstract][Full Text] [Related]
5. Different ways to describe the benefits of risk-reducing treatments: a randomized trial. Halvorsen PA; Selmer R; Kristiansen IS Ann Intern Med; 2007 Jun; 146(12):848-56. PubMed ID: 17577004 [TBL] [Abstract][Full Text] [Related]
7. Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. Harmsen CG; Kristiansen IS; Larsen PV; Nexøe J; Støvring H; Gyrd-Hansen D; Nielsen JB; Edwards A; Jarbøl DE Br J Gen Pract; 2014 Apr; 64(621):e199-207. PubMed ID: 24686884 [TBL] [Abstract][Full Text] [Related]
8. Decisions on drug therapies by numbers needed to treat: a randomized trial. Halvorsen PA; Kristiansen IS Arch Intern Med; 2005 May; 165(10):1140-6. PubMed ID: 15911727 [TBL] [Abstract][Full Text] [Related]
9. Effects of presenting risk information in different formats to cardiologists. A Latin American survey. Borracci RA; Piñeiro DJ; Arribalzaga EB Arch Cardiol Mex; 2015; 85(1):3-8. PubMed ID: 25450431 [TBL] [Abstract][Full Text] [Related]
10. Treatment decision-making and the form of risk communication: results of a factorial survey. Hembroff LA; Holmes-Rovner M; Wills CE BMC Med Inform Decis Mak; 2004 Nov; 4():20. PubMed ID: 15546488 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis. Griffith JM; Lewis CL; Hawley S; Sheridan SL; Pignone MP Med Decis Making; 2009; 29(2):167-74. PubMed ID: 19279298 [TBL] [Abstract][Full Text] [Related]
12. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. Kristiansen IS; Gyrd-Hansen D; Nexøe J; Nielsen JB J Clin Epidemiol; 2002 Sep; 55(9):888-92. PubMed ID: 12393076 [TBL] [Abstract][Full Text] [Related]
13. Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark. Kristiansen IS; Gyrd-Hansen D; Nexøe J; Bo Nielsen J Prev Med; 2006 Jul; 43(1):31-5. PubMed ID: 16678893 [TBL] [Abstract][Full Text] [Related]
14. Influence of number needed to treat, costs and outcome on preferences for a preventive drug. Nexøe J; Kristiansen IS; Gyrd-Hansen D; Nielsen JB Fam Pract; 2005 Feb; 22(1):126-31. PubMed ID: 15640298 [TBL] [Abstract][Full Text] [Related]
15. Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. Dahl R; Gyrd-Hansen D; Kristiansen IS; Nexøe J; Bo Nielsen J BMC Med Inform Decis Mak; 2007 Mar; 7():8. PubMed ID: 17394656 [TBL] [Abstract][Full Text] [Related]
16. [The number needed to treat (NNT) and the number needed to harm (NNH)]. Suter K; Briel M; Günther J Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396 [TBL] [Abstract][Full Text] [Related]
17. Treatment effect expressed as the novel Delay of Event measure is associated with high willingness to initiate preventive treatment - A randomized survey experiment comparing effect measures. Berglund E; Westerling R; Sundström J; Lytsy P Patient Educ Couns; 2016 Dec; 99(12):2005-2011. PubMed ID: 27499030 [TBL] [Abstract][Full Text] [Related]
18. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis. Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069 [TBL] [Abstract][Full Text] [Related]
19. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat. Gensini GF; Conti AA Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269 [TBL] [Abstract][Full Text] [Related]
20. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions. Timmermans DR; Ockhuysen-Vermey CF; Henneman L Patient Educ Couns; 2008 Dec; 73(3):443-7. PubMed ID: 18722073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]